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ABSTRACT 
The overall aim of this thesis was to evaluate the clinical usefulness of certain 
measurement techniques that may be helpful in the understanding of functional 
dyspepsia (FD).  
Electrogastrography (EGG) parameters were evaluated and found unable to 
discriminate one specific motility disorder from other motility disorders of the gut. 
Moreover the relationship between the electrical activity of the stomach determined by 
EGG and contractile activity of the gastric antrum assessed by antro-duodenal 
manometry (ADM) were analyzed and no spatial correlation between EGG and ADM 
was observed. These results suggest that the clinical usefulness of EGG in the diagnosis 
of a motility disorder is generally poor and EGG and ADM measure two different 
aspects of gastric physiology.  
The validity of 14C urea breath test (UBT) was compared with histology and rapid 
urease test (RUT) for the diagnosis of H. pylori infection. Both sensitivity and 
specificity of 14C UBT for the diagnosis of H. pylori infection were high. This study 
also indicated a very good concordance between UBT, histology, and RUT for the 
diagnosis of H. pylori infection. These observations suggest that 14C UBT is a reliable 
test for diagnosis of H. pylori infection.  
Satiety drinking tests were done in healthy volunteers by using drinking water at 100 
ml/minute and nutrient drinks at 20 and 100 ml/minute. It was found that the maximum 
tolerated volume (MTV) determined by slow nutrient drinking (SND) was not 
influenced by body mass index, age and gender compared to rapid water and rapid 
nutrient drinking. Moreover there was more symptom generation after drinking nutrient 
liquid at a slow rate. These results suggest that SND is more meaningful in the 
assessment of MTV. This study also determined the normal values of MTV for satiety 
drinking tests in a Pakistani population.   
The relationship between MTV and dyspepsia symptoms in patients with FD before 
and after the treatment was assessed. We found a significant correlation between 
dyspepsia symptom severity scores and MTV. Some of the individual symptom 
severity scores also correlated with MTV before and after treatment. The findings of 
  
this study indicate that determination of MTV by SND can be a surrogate marker for 
symptoms severity in patients with FD. 
This thesis concluded that the diagnostic usefulness of EGG is limited, that 14C UBT is 
a reliable test for the diagnosis of H. pylori infection, that SND is a better test for the 
assessment of MTV compared to rapid water and nutrient drinking, and that MTV 
determined by SND may be useful for the assessment of response to treatment in 
patients with FD. 
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1 INTRODUCTION 
Dyspepsia is derived from the Greek words dys and pepse, which mean an upset 
stomach or indigestion. The term functional dyspepsia was coined by one of the most 
well-known medical writers, Walter Clement Alvarez (1884-1978). He was a physician 
who investigated the electrical activity of the stomach and was also the inventor of 
electrogastrography (EGG) - a new diagnostic technique.  
 
1.1 Historical perspective 
In the early 18th century dyspepsia was classified into dietary, moral or nervous 
dyspepsia (1). Sir Charles Darwin’s illness in the 18th century provides an interesting 
link to functional dyspepsia. Charles Darwin’s adult life was affected by repeated 
gastric symptoms which severely compromised his quality of life. Darwin 
intermittently suffered from a combination of symptoms: malaise, vertigo, muscle 
spasms, vomiting, abdominal colics, bloating, nocturnal intestinal gases, headaches, 
severe tiredness, nervous exhaustion, dyspnea, depression and many more. Several 
explanations were given for his illness, including diseases like Meniere’s diseases, 
Chaga’s disease, cyclic vomiting syndrome, nervous dyspepsia and most recently 
according to Barry Marshall H. pylori infection (2).  
A German internist, Wilhelm Otto Leube (1842-1922), is remembered for his work 
with gastric and intestinal disorders notably his research in nervous dyspepsia (3). 
Leube believed that gastric irritation was often caused by the effects of food on the 
sensory nerves of the stomach. Leube performed extensive studies on indigestion and 
introduced a procedure known as ‘intubation’ to retrieve gastric contents for analysis. 
He also introduced ‘test meals’ of different types of food, which were later retrieved 
from patients via Leube’s “gastric tube”. This helped him to estimate the degree of 
digestion of the test meal, as well as the quantity and concentration of acid and pepsin 
in the patients’ stomach.  He developed the Leube-Rosenthal Meat Solution in 
collaboration with Isidor Rosenthal - a physiologist. 
An upsurge in the subject of functional dyspepsia (FD) came after the re-discovery of 
H. pylori by Barry Marshall and Robin Warren as a cause of peptic ulcer disease in the 
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early 1980s (4). Later in the 1980s the Rome process evolved and elaborated symptom 
criteria for defining functional dyspepsia. Despite extensive research in the etio-
pathogenesis of functional dyspepsia, FD remains a heterogeneous disorder of 
unknown etiology, unsatisfactory treatment, diverse manifestations, and unpredictable 
course. 
  
1.2 The Rome process 
The "Rome process" is an international effort to formulate symptom criteria for the 
diagnosis of functional gastrointestinal disorders (FGID). The latter include irritable 
bowel syndrome (IBS), functional dyspepsia (FD) and several other functional 
disorders of gastrointestinal tract. The Rome criteria are issued after passing through a 
consensus process, using the Delphi technique (5). The Rome process typically takes 
many months of work by investigators, organized into various committees. The 
committees work by mail and telephone conferences until the final meeting, which 
takes place in Rome, Italy.  
1.2.1 Rome I 
In 1991, the Rome committee defined dyspepsia as persistent or recurrent abdominal 
pain or abdominal discomfort centered in the upper abdomen (6). According to this 
definition, abdominal discomfort could be a post-prandial fullness, bloating, nausea, 
vomiting, belching or early satiety. Symptoms can occur continuously or intermittently. 
Rome criteria identified three categories of dyspepsia: (i) dyspepsia with an identified 
cause that if treated led to improvement, such as chronic peptic ulcer disease, reflux 
esophagitis, malignancy, or hepatobiliary disease; (ii) dyspepsia with identified 
abnormalities of uncertain significance like H. pylori infection and gastroparesis; and 
(iii) dyspepsia with no explanation identified. The term FD was used for dyspepsia with 
identified underlying mechanisms of uncertain significance or dyspepsia for which no 
explanation was available. 
The definition of FD was further elaborated by dividing it into three subgroups; (i) 
ulcer-like dyspepsia with predominant pain symptoms localized to the upper abdomen, 
relieved by taking food or antacid or H2 antagonist or proton pump inhibitors. (ii) 
dysmotility -like dyspepsia where three or more of the following symptoms; early 
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satiety, nausea, recurrent retching or vomiting, bloating without visible distension, or 
abdominal discomfort often aggravated by food. The latter subgroup excludes 
abdominal pain as the predominant symptom (iii) unspecified FD.  
Moreover all dyspeptic symptoms should be present for at least three months. In the 
first version of the Rome criteria a fourth group (reflux-like dyspepsia) was also 
defined (7).This was deleted in the Rome 1991 paper.  
1.2.2 Rome II 
In 1999, the Rome committee partially changed the criteria for dyspepsia, although the 
definition of dyspepsia was not altered (8). The committee’s main focus was to align 
one specific predominant symptom with underlying Rome I based sub-groups of FD as 
defined above. The purpose of categorizing sub-groups of FD by a predominant 
symptom was to target treatment towards the predominant symptom. Rome II also 
revised the reporting duration of all symptoms. It elaborated that the symptoms had to 
be present for at least 12 weeks over a 12 months period which need not to be 
consecutive. 
Both Rome I and II criteria for FD received criticism. It was observed that patients 
were frequently unable to distinguish abdominal pain from discomfort. The word 
predominant symptom (Rome II ) was ambiguous and classifying patients based on 
symptoms could not identify subgroups with homogeneous underlying patho-
physiological mechanisms.  The duration and time course specification for dyspepsia 
also deemed to be clumsy (9).  
1.2.3 Rome III 
In 2006, the Rome committee made several changes of the functional dyspepsia 
classification (10). The committee described a more elaborative localization of the pain 
in the epigastric area. The term abdominal discomfort was abandoned and the key 
concept was replaced by the terms post-prandial fullness and early satiety. Rome III 
changed the predominant symptom-based sub-groups of FD into new categories with 
several symptoms into each category. The term functional dyspepsia was abandoned 
for research purposes in favor of a more detailed classification of functional gastro-
duodenal disorders Table 1.  
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Table1. Functional gastro-duodenal disorders according to the Rome-III classification (10). 
B1. Functional dyspepsia 
B1a. Postprandial distress syndrome 
 
B1b. Epigastric pain syndrome  
B2. Belching disorders 
B2a. Aerophagia 
 
B2b. Unspecified excessive belching 
B3. Nausea and vomiting disorders 
B3a. Chronic idiopathic nausea 
B3b. Functional vomiting  
B3c. Cyclic vomiting syndrome 
B4. Rumination syndrome in adults  
 
1.3 Epidemiology of functional dyspepsia  
In clinical practice dyspepsia is a very common condition and up to one in 20 of all 
consultations in primary health care are for dyspepsia symptoms (11). A review by 
Agréus reported the prevalence of dyspepsia to range from 7-63 % while another 
review estimated it to be 2.5% - 41% (12, 13). This wide range is due to variability in 
the definition of dyspepsia.  In a Swedish population based upper endoscopy study, the 
prevalence of FD was 16% and in another recently published population-based study 
showed that FD was present in 11% of the Italian general population (14, 15). The same 
study also documented that two distinct sub-groups of FD as described in Rome III 
exist in the general population.  
Functional dyspepsia is a heterogeneous disorder with a fluctuation of symptoms and 
very little is known about its natural history. Symptoms of FD shift back and forth with 
gastro-esophageal reflux disease (GERD) and IBS. Studies have demonstrated both 
short-term and long-term fluxes of dyspeptic symptoms (12, 16).  A study from Sweden 
noted some symptom fluctuation in the shorter term, but troublesome gastrointestinal 
complaints remained in approximately 90% of subjects over a 1-6 month period (17).  
In Japan, a 40 % prevalence of functional gastrointestinal diseases (FGID) was 
observed with overlapping functional bowel disorders (18).  
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1.4 Physiological dysfunctions in functional dyspepsia 
FD is associated with physiological dysfunctions in the gastro-duodenal region. 
However, there is no uniform pattern of patho-physiological abnormalities found in all 
FD patients. Various mechanisms have been described.  
1.4.1 Impaired gastric emptying 
Studies have shown delayed gastric emptying occurs in approximately 20-50% of 
patients with FD (19, 20). In a meta-analysis of 17 studies, involving 868 patients with 
dyspepsia and 397 controls, significant delay of solid gastric emptying was present in 
almost 40% of patients with FD (21). However, some studies have documented a very 
weak association between delayed gastric emptying and dyspepsia symptoms (22, 23). 
In a subset of patients with FD, rapid gastric emptying has also been observed (24). 
Hence the relationship between FD and gastric emptying is not unified and remains 
controversial.  
1.4.2 Increased visceral hypersensitivity 
Increased perception of visceral stimuli has been considered as one of the major patho-
physiological mechanisms in functional gastrointestinal disorders (25). Studies have 
demonstrated that a sub-set of patients with FD have enhanced sensitivity to isobaric 
gastric distension (26, 27). The exact site of hypersensitivity generated in these patients 
is however unknown. Two possible sites for generating hypersensitivity in these 
patients are the central nervous system and enteric nervous system especially visceral 
afferents.  
In context with visceral hypersensitivity, several receptors have been identified as 
potential targets for future drug development. These include transient potential receptor 
vanilloid type I (TPRV1), voltage-gated sodium channels, ATP, acid sensing ion 
channel (ASICs), PAR-2, cannabinoid, prostaglandin, tachykinin, and 5HT-receptors 
(28).  
1.4.3 Impaired gastric accommodation 
Accommodation of the stomach is a vagus nerve-mediated reflex resulting in receptive 
relaxation of the proximal stomach after intake of a meal. Gastric accommodation 
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provides the meal with a reservoir and enables the stomach to handle intra-gastric 
volumes without a proportional increase of intra-gastric pressures. It is speculated that 
impaired accommodation of the proximal stomach during and after the ingestion of a 
meal may be accompanied by increase in intra-gastric pressure which activates 
mechanoreceptors in the gastric wall, thus inducing dyspeptic symptoms. Using a 
barostat, impaired gastric accommodation was demonstrated in 40% of patients with 
FD who presented with symptoms of early satiety and weight loss (29, 30).  
1.4.4 Other putative pathogenetic mechanisms for FD  
Bacterial gastroenteritis in adults may be a predisposing factor for FD in a subset of 
patients (31, 32).  
Similarly untreated celiac disease is associated with intestinal inflammation. In 
untreated celiac disease, a high prevalence of delayed gastric emptying and of 
abnormalities on antroduodenojejunal manometery was found (33, 34). A gluten-free 
diet normalized gastric emptying rate (33), whereas persistence of motor abnormalities 
on antroduodenaojejunal manometry was associated with ongoing mucosal 
abnormalities suggestive of incomplete dietary adherence (34). Food intolerance has 
been debated for a long time as a factor causing functional dyspepsia. In patients with 
food intolerance, ingestion of a meal is associated with a rise in dyspeptic symptoms 
which is significant within 15 min after the start of the meal, and persists for at least 4 
hours post-prandially (35). The underlying mechanism is unclear but sensorimotor 
dysfunction is a likely possibility (35, 36). Autonomic imbalance especially impaired 
vagal activity has also been implicated in the pathogenesis of FD (37). 
 
1.5 Symptoms and patho-physiological mechanisms based 
categorization of FD 
Attempts have been undertaken to classify patients with FD according to types or 
groups of symptoms that would reliably identify patients with different underlying 
patho-physiological mechanisms. This would help in directing therapy towards the 
underlying patho-physiology (38). However in clinical practice this classification 
showed great overlap between subclasses. Moreover a detailed analysis has revealed 
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that the predominant symptom does not reliably identify patho-physiological subsets 
(39, 40). 
In a slightly different approach patho-physiology-based sub-groups of FD were formed 
and an attempt was made to find association between patho-physiological abnormalities 
and the dyspepsia symptoms (41). Thus, associations were demonstrated between 
delayed gastric emptying and symptoms of fullness, nausea, and vomiting (41). 
Moreover an association was also found between impaired fundic accommodation, 
early satiety and weight loss (41). A recent study on a large group of patients with FD 
in a tertiary care setting performed factor analysis of symptom patterns.  This study 
showed that in patients with FD the presence of weight loss was strongly associated 
with early satiety and also with nausea and vomiting (42).  
 
1.6 Etiologic factors associated with FD 
Several factors have been suggested to play a significant role in the etiology of FD. 
1.6.1  Genetic factors  
There is increasing evidence that susceptibility to functional GI disorders is influenced 
by the presence of genetic factors (43). Homozygous GNB3 825C carrier status was 
found to be associated with unexplained predominantly upper abdominal symptoms 
(44). Recently, a study identified post-prandial distension syndrome (PDS) in Japanese 
male subjects with cholecystokinin intron carrier state (45). Similarly, another study 
from Japan showed association of IL-17F and MIF gene polymorphisms with the 
development of FD in H. pylori-infected patients (46).  
1.6.2 Psychosocial disorders  
A high score on psychomotor scale has been observed among patients with FD 
compared to normal individuals.  Study has suggested that psychosocial stress, mood 
symptoms and coping style are the major predictors of FD (47). A recent population-
based study found that anxiety was linked to uninvestigated dyspepsia and FD (14). 
The same study, however, did not find depression as an associated factor in patients 
with FD. 
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1.6.3 Helicobacter pylori  
Several attempts have been made to determine if there is a relationship between H. 
pylori infection and functional dyspepsia. However, no consistent difference in the 
prevalence or severity of individual dyspeptic symptoms and physiological dysfunction 
were found between H. pylori positive and negative subjects (23). Moreover, the effects 
of eradication of H. pylori on epigastric symptoms of dyspepsia are debatable. A 
Cochrane meta-analysis suggested a small but significant beneficial effect of 
eradicating H. pylori on symptoms associated with FD (48). Therefore, the influence of 
H. pylori on the pathogenesis and symptom generation in patients with FD remains 
unclear.  
 
1.7 Measurement techniques in FD 
FD is a diagnosis of exclusion referring to absence of typical symptoms of GERD, and 
a normal upper GI endoscopy. There is no specific test or a biomarker available for the 
diagnosis of FD. However certain measurement techniques have been used for the 
evaluation of pathological changes and physiological dysfunction in patients with FD.  
Most of these measurement techniques require a tertiary care setting and their 
feasibility for the daily clinical practice is doubtful. 
1.7.1 Magnetic resonance imaging (MRI)  
MRI is a non-invasive and radiation-free technique, which can be use for the 
assessment of gastric emptying of both solids and liquids. An initial validation study 
showed good agreement between MRI and single photon emission computerized 
tomography (SPECT) for both solid and liquid meal gastric emptying (49).  It is now 
possible to assess the gastric motility index (calculated from the frequency, amplitude, 
velocity and moving distance of peristaltic waves in the gastric antrum) reliably with 
MRI (50). The reproducibility of MRI in the assessment of gastric emptying and antral 
motion has been established (51). A recent study demonstrated MRI to be a sensitive 
technique for simultaneous measurement of gastric emptying and gastric motility index 
(52). The prolonged procedure time and   positioning of the patient however have some 
technical and general limitations.    
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1.7.2 Single photon emission computerized tomography (SPECT)  
SPECT is a non-invasive technique considered to be a gold standard in the assessment 
of gastric emptying. This technique has been extensively validated for the measurement 
of gastric volumes (53). When tested for reproducibility by using same caloric meal the 
coefficient of variation was approximately 10%. Gastric volume estimation by SPECT 
is a surrogate marker of gastric accommodation as well. A new application of SPECT 
(with significant potential interest) is the simultaneous measurements of gastric 
emptying and volume (54) 
In comparison with Barostat, SPECT is a non-invasive method. However, SPECT 
cannot provide information about gastric tone, nor about gastric sensory responses. The 
SPECT technique is promising for investigation of gastric volumes in health and 
disease and for the assessment of the effects of pharmacological agents on gastric 
volume and emptying (41). 
1.7.3 Barostat measurement 
The barostat technique is regarded as the gold standard for assessing gastric 
accommodation. A 1200 ml balloon is passed into the stomach and unfolded by 
inflation of 500ml air and then positioned in the proximal stomach. The bag is 
connected to a pump through a double lumen tube. The pump is computer-controlled 
and can maintain a constant pressure or a constant volume of the bag. Both gastric 
sensitivity and accommodation can be studied using the barostat (55, 56). However, the 
barostat technique is invasive, uncomfortable and stressful for the patient.  
1.7.4 Ultrasonography  
Ultrasonography is a non-invasive technique, which has been tested for the assessment 
of gastric emptying, antral motility and trans-pyloric flow. Assessment of gastric 
accommodation by ultrasonography is evolving and two-dimensional ultrasonography 
of the proximal stomach has been used to demonstrate volume changes after meal and 
its impairment in patients with FD (57-61).  Recently real time ultrasound technique 
has been used for the assessment of trans-pyloric flow and duodeno-gastric reflux (62). 
Ultrasonography has the advantage of being widely available. However, 
ultrasonographic assessment of gastric motility disorders requires technical expertise 
and the interpretation is operator dependent.    
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1.7.5 Antro-duodenal manometry (ADM) 
The gastric antrum and duodenum generate lumen-occluding pressure activities, which 
are suitable for manometric recordings because of relatively narrow lumen of antro-
duodenal region compared to the body of stomach. ADM is an invasive test, involving 
intestinal intubation and fluoroscopy for accurate catheter placement.  Currently, this 
technique is used to differentiate whether the documented slow gastric or small bowel 
transit is due to neuropathy, myopathy or undetected mechanical obstruction. ADM is 
also indicated for the diagnosis of intestinal pseudo-obstruction (63). The role of antro-
duodenal manometry is limited because of the technical challenges involved in its 
performance and the expertise required for its interpretation (64).  
1.7.6 Electrogastrography (EGG) 
Electrogastrograpy was introduced early in the 20th century (65). This test measures the 
slow wave electrical activities trans-cutaneously from the gastrointestinal (GI) tract. 
EGG is non-invasive and practically feasible. EGG detects rhythm and power 
(amplitude) of gastric myoelectricity. Studies have shown a good correlation between 
cutaneous EGG recordings and myoelectrical signals recorded from gastric serosal 
leads (66).  
Although feasible, there are major concerns regarding the clinical usefulness of EGG. 
The placing of electrodes, skin preparation, stomach distension/contraction and EGG 
filtering and recording systems all influence the obtained EGG parameters. Moreover, 
there are no standard recommendations for the position of the patient during recording, 
recording periods and test meals. Lack of standardization for the equipment used to 
conduct EGG and the software for analysis of wave forms also remains a challenge. It 
appears that an acceptable consensus is needed to define the abnormalities based on the 
EGG recording when it is used to assess stomach motor dysfunction (67, 68) 
1.7.7 Satiety drinking test 
The satiety drinking test has been proposed as a surrogate method for estimating gastric 
volumes. Several versions of this test are available that differ from each other by the 
nature of liquid use for drinking (water, nutrient drink or meat soup) and the speed of 
drinking, ranging from 15 to 100 ml/min (29, 69). A previously published study has 
suggested that a high-caloric, slowly administered drinking test compares favorably 
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with the barostat in predicting impaired gastric accommodation (69). Satiety drink test 
is inexpensive and non-invasive. However there is ongoing controversy whether the 
satiation test reflects exclusively gastric accommodation or a combination of 
accommodation, sensation, and emptying (70). 
1.7.8 Breath tests 
1.7.8.1 13C-octanoic acid breath test 
Solid meal gastric emptying can be determined by 13C-octanoic acid breath test.  The 
nonradioactive isotope, 13C is usually bound to a medium chain triglyceride (octanoic 
acid) which is incorporated into a standardized test meal. The 13C-labeled substrate is 
ingested, emptied by the stomach, and absorbed in the proximal gut. This is a 
reproducible technique with a very low inter-individual variability (71, 72). The 
substrate that is commonly used to measure gastric emptying of solids by breath test is 
the 13C-octanoic acid. The substrate is rapidly absorbed in the duodenum, metabolized 
in the liver where 13CO2 is formed and then exhaled rapidly in the breath (73). Octanoic 
acid breath test is a safe and radiation-free technique. The 13C-octanoic acid breath test 
gives an indirect measure of gastric emptying and results may depend upon several 
factors such as the patient’s age, weight and the level of physical activity during the 
test. Results can also be influenced by catabolic states and intestinal bacterial 
overgrowth. However, a recently published study with a large sample size showed a 
very small effect of such factors on the estimation of gastric emptying by 13C octanoic 
acid breath test (74).  
1.7.8.2 Urea breath test (UBT) 
Urea breath test is one of the most reliable non-invasive techniques for the diagnosis of 
H. pylori infection. It comes in two versions 14C and 13C isotopes of carbon; the former 
is radioactive while the latter is not. This test is based upon the property of H. pylori to 
produce urease, an enzyme that splits urea into ammonia and bicarbonate. The carbon 
is liberated and it is measured in the exhaled air. Sensitivity and specificity are greater 
than 90% (75). However, there are certain limitations of using UBT in patients who 
were taking antibiotics and PPI, which may give rise to false negative results (76-78).  
 
 12 
1.8 Treatment of FD  
A strong physician-patient relationship is of the utmost importance in treating 
individual patient with FD so that reassurance and education may be provided. Dietary 
modification, such as ingestion of a low fat diet and small frequent meals may be 
beneficial, but data is scarce. Empiric acid suppression with H2-receptors angonist 
(H2RAs) or PPIs is likely superior to placebo in treatment of FD, but those patients 
with meal-related symptoms are least likely to respond. Acid reduction is effective in 
reducing symptoms up to 35% of patients with non-ulcer dyspepsia, possibly due to 
unrecognized non-erosive reflux disease (79).  
1.8.1 Helicobacter pylori eradication 
Test and treat strategy for associated H. pylori infection is recommended for patients 
with uninvestigated dyspepsia when there are no alarming features. Eradication of H. 
pylori is a preferable strategy for patients with uninvestigated dyspepsia in areas where 
prevalence of H. pylori is 20% or higher (80). A Cochrane meta-analysis has shown a 
small but significant benefit from eradication of H. pylori in patients with FD that will 
reduce the risk of symptoms by 10% and NNT required to improve the condition of one 
patient is 14 (48 ).  
1.8.2 Prokinetics 
Experience with the use of prokinetics in functional dyspepsia is limited. Domperidone 
which is a D2 antagonist that acts peripherally to increase antral motility; therefore, less 
potential for central side effects exists. One trial comparing metoclopramde and 
domperidone demonstrated no significant difference (81). Domperidone is not freely 
available worldwide. There are some other emerging prokinetic agents such as itopride 
which is D2 receptor antagonist with acetylcohlinesterase inhibitory and low central 
activities. However the clinical usefulness of itopride in FD patients is controversial 
(82). Erythromycin a motilin agonist stimulates gastric and duodenal motility by acting 
on smooth muscles and enteric nerves. Erythomycin may promote gastric emptying but 
does not improve dyspeptic symptoms.  There are issues of tachyphylaxis and 
impairment of meal induced gastric accommodation with the use of erythromycin (83).  
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1.8.3 Antidepressants  
Selective serotonin reuptake inhibitors (SSRI) increase the amount of serotonin within 
the synapse by inhibiting the serotonin reuptake transporter in both the CNS and ENS. 
This leads to increased availability of serotonin to the enteric nerves, which may alter 
sensorimotor functions of the gut. Almost no data regarding the efficacy of SSRIs in 
the treatment of patients with FD exist.  
Tricyclic antidepressants (TCA) block serotonin and nor-epinephrine reuptake pumps. 
Hence, TCA have the potential to stimulate serotonin and noradrenergic neurons and 
thus affect sensorimotor functions of the gut, as well as analgesic pathways. Very few 
studies with TCAs in the treatment of FD have been completed. Amytriptiline- a TCA 
has shown decreased perception of symptoms compared to placebo in patients with FD 
but it was not associated with decreased perception to gastric distension (84). 
1.8.4 Other agents for treatment of functional dyspepsia 
Visceral hypersensitivity is increasingly recognized as a patho-physiologic mechanism 
of FD. Possible therapeutic targets include certain receptors involved in perception such 
as opioid, neurokinin and vanilloid receptors. Drugs targeting receptors involved in 
pain perception, are under development, yet no conclusive data is available to support 
their use at present (85). 
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2 AIMS OF THE STUDY 
The overall aim of this project was to evaluate the clinical usefulness of certain 
measurement techniques that may aid in the understanding of FD.  
Study I 
To evaluate the relationship between the electrical activity of the stomach determined 
by electrogastography and antral contractile activity measured by antro-duodenal 
manometry and to study whether the underlying motility disorder could be predicted 
from EGG parameters.  
Study II 
To determine the validity and cost of microdose 14C-UBT in comparison with histology 
and rapid urease test for the diagnosis of H. pylori infection. 
Study III 
To compare the maximum tolerated volume (MTV) of taking water and a nutrient 
liquid at two different rates of drinking and to assess the effects of age, gender and 
body mass index on MTV.  
Study IV 
To find out if there is a relation over time between changes in gastric accommodation 
determined by a satiety drinking test and changes in symptom severity scores in 
patients with functional dyspepsia after four weeks of treatment. 
   15 
3 MATERIAL, METHODS, AND STUDY DESIGN 
Study I was a retrospective analysis done on a preexisting large data set of patients with 
motility disorders who underwent a combined antro-duodenal manometry and EGG test 
for the evaluation of their disease. Study II, III, and IV were prospectively designed. 
Materials, methods and study designs are summarized in Table 2.  
Table 2. Summary of material, methods, and study design. 
 
Study I II III IV 
No. of 
participants 
148  94 42 132 
Design Retrospective 
Observational 
Prospective 
Experimental 
validation 
Prospective 
Experimental 
Prospective 
Interventional 
Data source 
and Method 
Medical 
records 
Functional 
dyspepsia 
patients who 
underwent 
endoscopy, 
urea breath test, 
rapid urease 
test, and gastric 
biopsy with 
histology 
Healthy 
volunteers 
Satiety drinking 
tests 
Functional dyspepsia 
patients, who underwent  
endoscopy,  urea breath 
test, satiety drinking test. 
These patients received 
proton pump inhibitor 
and/or anti-H. pylori 
treatment. Urea breath 
test and satiety drinking 
test were repeated after 
treatment 
Data 
analysis 
Descriptive 
and statistical 
analysis 
Descriptive and 
statistical 
analysis 
Descriptive and 
statistical 
analysis 
Descriptive and 
statistical analysis 
3.1 Study I 
The data was collected between 1994-2001. A total of 148 patients were evaluated for 
EGG parameters and 144 for correlations between EGG and ADM parameters. There 
were 21 EGG variables and 8 ADM variables that were analyzed and compared. A 
single channel EGG was used and Polygram version 6.40 was applied for data analysis. 
Similarly ADM was performed by a flexible 6-8 channel catheter connected to a 
pneumo-hydraulic pump. Data logging was done with a Polygraph 12HR and the 
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Polygram (Medtronic Synectics, Stockholm, Sweden) software. The protocol included 
a 3-hour fasting period followed by a test meal (500 kcal standardized mixed meal) and 
a 2-hour post-prandial recording. 
 
3.2 Study II 
Consecutive patients with dyspeptic symptoms, undergoing upper GI endoscopy were 
enrolled. During upper GI endoscopy, gastric biopsies were taken for histopathological 
examination and rapid urease test. A 14C-UBT was done by asking the patient to 
swallow 37 kBq (1 uCi) of an encapsulated form of 14C-urea/citric acid composition 
(Helicap, Noster System AB, Stockholm, Sweden) with water after endoscopy. Breath 
samples were collected with a special dry cartridge system 10 minutes after swallowing 
the UBT capsule. Results were expressed both as counts per minute (CPM) and as 
grade (0: not infected; CPM < 25, 1: equivocal; CPM 25-50, 2: infected; CPM > 50), 
which was suggested by the manufacturer according to the counts obtained from the 
cartridges. Grades 0 and 1 were considered negative for the detection of H. pylori.  
 
3.3 Study III 
This study comprised 42 healthy adult volunteers who were free from any 
gastrointestinal disease, had no abdominal complaints, and no history of abdominal 
surgery. They were subjected to satiety drinking tests on three different occasions. On 
the first occasion, subjects were also interviewed and their gender, age, height, weight, 
and BMI were recorded. On subsequent visits the other two drinking tests were taken. 
The study subjects drank plain water at a rate of 100 ml/min in one test (RWD = rapid 
water drinking). In the other two tests, study subjects drank a nutrient drink at a rate of 
100 ml/min (RND = rapid nutrient drinking) or 20 ml/min (SND = slow nutrient 
drinking). During satiety drinking tests the study subjects scored their satiety level 
using a graphic rating scale that combined verbal descriptors on a scale graded from 0 
to 5. Study subjects were instructed to stop drinking when they reached a score of 5. 
Symptoms of bloating, nausea, and abdominal pain were graded on a visual analogue 
scale (0-100) 30 min after cessation of drinking. 
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3.4 Study IV 
Patients with FD were enrolled after initial screening by a Rome-III based 
questionnaire. All patients underwent a diagnostic esophago-gastro-doudenoscopy 
(EGD). Patients with gastric or duodenal erosions as well as those with ulcers, polyps 
or malignancy were excluded. Similarly, patients with predominant symptoms of 
GERD or endoscopic evidence of esophagitis were excluded. Patients with abnormal 
complete blood count, liver function tests, creatinine or abnormal upper abdominal 
ultrasound investigation were also excluded and so were patients who had received 
antibiotics in the last two weeks (e.g. clarithromycin, amoxicillin or metronidazole) or 
who had been treated in the past for H. pylori infection or received non-steroidal anti-
inflammatory drugs (NSAIDs). A 14C-urea breath test (UBT) was done in all patients 
after EGD. Patients were considered to have H. pylori infection if they had both 
positive UBT and evidence of H. pylori on histology. A satiety drinking test using 
nutrient drink at a rate of 30 ml/min was done in all patients before and 10 days after 
completion of four weeks' treatment. Dyspeptic symptom severity was scored using a 
global overall symptom scale (GOS) at the same timepoints as the drinking test. 
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4 STATISTICAL METHODS  
Descriptive analyses were done in all four studies and results were expressed as mean ± 
SD. In study I, logarithmic transformation was done for some data that was not 
normally distributed. Specific statistical methods applied in each study are described in 
Table 3. Description and rationale of some statistical tests used in the analysis of the 
studies presented in this thesis are described below. 
 
4.1 Student’s t-test 
Student’s t-test is applied to analyze research questions involving two means. The t-test 
assesses whether the means of two groups are statistically different from each other. 
Student’s t-test can be use to assess the differences of the means between two 
independent samples (unpaired t-test) or between two measurements in the same 
sample (paired t-test).  In study IV, the assessment of MTV was done before and after 
treatment. Since the same study subjects were compared for assessment, the paired t-
test was used.  
 
4.2 Mann-Whitney U-test  
This is one of the best known non-parametric tests for comparing two independent 
samples of observations if the normality assumptions are not satisfied. In study I the 
data for EGG variables was transformed to logarithmic values in order to make 
variables more normally distributed. Some EGG variables in study I (such as 
percentages of normogastria, bradygastria, tachygastria and dominant frequency) were 
not normally distributed and these were analyzed with Mann-Whitney U-test.  
 
4.3 Log-rank test  
This test is sometimes called the Mantel-Cox test. It is used for comparing the survival 
distributions of two samples. It is a non-parametric test widely used in clinical trials to 
establish the efficacy of a new treatment compared to a control treatment when the 
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measurement is the time to an event (such as time from initial treatment to a heart 
attack). In study III, the log-rank test was used for comparing maximum tolerated 
volumes between male and female groups. The event in study III was the achievement 
of complete satiety that prevents further drinking of nutrient liquid. Instead of time we 
have the amount of nutrient drink that was ingested before reaching the maximum 
satiety. Since a specified amount of nutrient liquid per time unit was taken, volume 
becomes a surrogate marker for time and it was feasible to use the log-rank test. 
 
4.4 Analysis of variance (ANOVA)  
One-way ANOVA is a statistical test which compares the means of several groups and 
therefore generalizes students two sample t-test to more than two groups. In study III, 
ANOVA was used to compare the three different satiety drinking tests and symptoms 
score that the study subjects developed. 
 
4.5 Pearson’s correlation 
In statistics, the Pearson’s product-moment correlation coefficient (sometimes referred 
to as PMCC, and typically denoted by ‘r’ is a measure of the correlation (linear 
dependence) between two variables X and Y, giving a value between +1 and −1 
inclusive. It is widely used in science as a measure of the strength of linear dependence 
between two variables.  A key mathematical property of the Pearson correlation 
coefficient is that it is invariant to changes in location and scale, i.e. changing the scale 
of either the X or the Y variable will not change the size of the correlation coefficient  
The Pearson’s correlation test was extensively applied in study I, III and IV. In study I, 
ADM variables were compared with EGG variables. Similarly, in study III, the MTV 
measured by three drinking tests were compared and the relationship between MTV 
with age and BMI was assessed by using Pearson’s correlation.  
In study IV, Pearson correlation was extensively utilized in order to understand the 
relationship between dyspepsia symptom severity scores and MTV. Correlations 
 20 
between dyspepsia symptoms and MTV were analyzed at baseline and after 4 weeks of 
treatment.  
Table 3. Summary of overall statistical methods applied in various studies. 
 
Study  Function Statistical method 
I II III IV 
Frequency distribution using mean 
with standard deviation, median with 
range and percentages 
Descriptive statistics X X X X 
Comparing means normally 
distributed data 
Student's  t-test   X  
Comparing ranks non-parametric  Mann-Whitney U-test X    
Comparing survival distribution in two 
samples 
Log-rank test   X  
Survival proportion of the groups Kaplan-Meier plot   X  
Comparing means of several  groups Analysis of variance   X  
Measure of correlation linear 
dependence  
Pearson's product moment 
correlation 
X  X X 
Explore the relationship between 
dependent and independent 
variables.  
Multiple linear  or logistic 
regression 
X  X X 
Reliability of a investigational test for 
diagnosis 
Specificity, sensitivity, negative 
and positive predictive values  
 X   
Adjusting p-values for multiple 
comparisons  
Bonferroni's test     X 
Agreement between observations  Cohen's kappa  X   
4.6 Multiple regression analysis 
Regression analysis is applied to understand which among the independent variables 
are related to the dependent variable, and to explore the forms of these relationships. 
When three or more measurement variables are available one of the measurement 
variables is the dependent (Y-axis) variable. The rest of the variables are the 
independent (X-axis) variables. The purpose of a multiple regression is to find an 
equation that best predicts the Y variable as a linear function of the X variables. We 
have used logistic regression in study I to determine EGG variables that were of 
independent value for predicting underlying diagnoses.  
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Multiple regressions were also used in study III and IV in order to evaluate the effects 
of various factors such as age, gender, weight and BMI on MTV.  
4.7 Sensitivity, specificity, and negative and positive 
predictive values 
The accuracy of a diagnostic test or procedure has two aspects. The first is the test’s 
ability to detect the condition it is testing for, thus being positive in patients who 
actually have the condition; this is the sensitivity of the test. If a test has high sensitivity 
it has low false negative rate. Sensitivity is the proportion of positive that are correctly 
identified by the test. The other aspect of the accuracy is the test’s ability to identify 
those who do not have the condition. This is called the specificity of the test. If the 
specificity of a test is high it has a low false positive rate. Specificity is the proportion 
of negatives that are correctly identified by the test.  
The positive predictive value of a test is the percentage of patients with a positive test 
result who actually have the condition. The negative predictive value of a test is the 
percentage of patients with a negative test who do not have the condition. In Study II all 
these tests were used to evaluate the validity of  14C-UBT in the diagnosis of H. pylori 
infection. 
 
4.8 Cohen’s kappa  
Agreement between two observations can be tested by a simple kappa statistic, it is 
denoted by κ which measures the level of agreement beyond that exepected by chance. 
When κ is zero the agreement is no better than chance expected agreement. Agreement 
less than chance returns a negative κ-value. A value of kappa ranging from 0.61-0.80 is 
considered a good agreement, > 0.81 – 0.90 very good and > 0.91 excellent (86).  
 
4.9 Bonferroni’s correction 
When several comparisons are made the probability of obtaining significance by 
chance is increased and the probability of making a Type-I error increases.  One way to 
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compensate for multiple comparisons is to decrease the alpha level by dividing the 
alpha level with the number of comparisons made. In study IV, We used Bonferroni's 
correction for multiple comparisons when analyzing correlations between MTV and 
individual symptom severity scores.  
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5 RESULTS 
 
5.1 Study I 
The study population included 148 patients for comparing EGG parameters among 
various diagnosis groups and 144 patients for assessing the correlation between EGG 
and ADM parameters. The median age of the patients was 45 (range 17-76) years and 
122 (82%) were females. There were 52 patients (35%) with IBS, 22 (15%) with 
enteric dysmotility, i.e. abnormal small bowel motor activity but no bowel dilatation, 
26 (18%) with slow transit constipation, 11 (7%) with chronic intestinal pseudo-
obstruction, 13 (9%) with functional dyspepsia with or without gastroparesis and 24 
(16%) with other diagnoses, including various systemic and neurological diseases. 
A correlation matrix between 21 EGG parameters and 8 ADM parameters was 
analyzed. Only a few and weak correlations were found between EGG and ADM. The 
comparison between the EGG response (ratio between postprandial and fasting power) 
and the ADM response to ingestion of a 500 kcal test meal (ratio between postprandial 
and fasting motility index) revealed no correlation (r = -0.07, P = 0.44), Figure 1. The 
ability of EGG to identify diagnostic groups was tested by comparing EGG parameters 
for each group against all other patients included. In general, the discriminatory power 
of EGG was low. Only patients with slow transit constipation showed a reasonable 
number of differences in postprandial EGG parameters compared to those in all other 
diagnosis groups.  
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Figure 1. Scatter plot of motility index ratio and power ratio in 144 patients 
(logarithmic scales).Symbols indicate different qualities of the EGG record:  
 
5.2 Study II 
Ninety-four consecutive patients with dyspeptic symptoms were enrolled for this study. 
They underwent 14C-UBT, rapid urease test, and gastric histology. There were 60 
(64%) men and the mean age of study group was 40.8 ± 12.8 years. H. pylori infection 
was diagnosed by histology in 66 (70%) patients and by rapid urease test in 61 (65%) 
patients. UBT detected active H. pylori infection in 63 (67%) patients. 
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In comparison with histology, UBT had a sensitivity of 92% (95% CI: 87%-95%) and a 
specificity of 93% (95% CI: 79%-99%). The positive predictive value (PPV) of 14C-
UBT was 97% (95% CI: 91%-99%) and the negative predictive value (NPV) was 84% 
(95% CI: 72%-89%) compared with histology (Table 4). These results showed that 
UBT had an accuracy of 93% compared to histology. Kappa test showed concurrence 
between the UBT diagnosis and histological diagnosis of H. pylori infection with value 
of 0.80 (p<0.001). 
In comparison with rapid urease test, the sensitivity and specificity of UBT was 98% 
(95% CI: 93%-99%) and 91% (95% CI: 80%-94%). PPV and NPV were 95% (95% CI: 
89%-97%) and 97% (95% CI: 86%-99%), respectively. UBT has an accuracy of 96% 
compared with rapid urease test for the diagnosis of H. pylori infection (Table 4). The 
result of the Kappa test was 0.88 (p< 0.001), which indicates a very good concurrence 
between rapid urease test and 14C-UBT.  
Four patients with histological evidence of H. pylori infection had negative results with 
UBT and rapid urease test. At the time of this study, the cost of gastroscopy was 90 
USD while the cost of histology and rapid urease test was 20 USD and 5 USD 
respectively in our institute. Therefore, the overall cost of H. pylori diagnosis by 
histology was 110 USD and 95 USD by rapid urease test. The cost of UBT was only 15 
USD in our institute. 
Table 4.  Sensitivity and specificity of 14C UBT against histopathology and rapid 
urease test for H. pylori diagnosis (n=94). 
UBT  
Compared to 
Sensitivity  
(95% CI) 
Specificity  
(95% CI) 
PPV 
(95% CI) 
NPV 
(95% CI) 
Accuracy 
 
Histopathology 92% 
(87-95) 
93% 
(79-99) 
97% 
(91-99) 
84% 
(72-89) 
93% 
Rapid urease test  98% 
(93-99) 
91% 
(80-94) 
95% 
(89-97) 
97% 
(86-99) 
96% 
UBT: urea breath test PPV: Positive predictive value: NPV: negative predictive value; 
CI: confidence interval  
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5.3 Study III 
Among 42 healthy volunteers MTV estimated by rapid water drinking was 1595 ±405 
ml in males and 1327 ±308 ml in females (p<0.05). In rapid nutrient drinking (RND), 
the average volume tolerated by males was 945 ±376 ml, whereas females tolerated 
760 ±174 ml (p<0.05). In slow nutrient drinking (SND) the tolerated amount of liquid 
was 692 ±184 ml in males and 594 ±131 ml in females (p=0.051). Both males and 
females tolerated significantly larger amounts of plain water at a rapid rate compared to 
the drinking of nutrient liquid either at a rapid or a slow rate. 
Kaplan-Meier plots demonstrated that in rapid nutrient drinking test, fewer calories 
were required to reach the maximum tolerance in females compared to males (Figure 
2a). However no significant difference in calorie requirement was observed between 
females compared to males on slow nutrient drinking test (Figure 2b).  
 
Figure 2a. Kaplan-Meier plot of rapid nutrient drinking (100 ml/min) to maximum 
satiety in males and females. Females needed a lower kcal load to reach maximum 
satiety; p<0.03 (log-rank test). RND = rapid nutrient drinking. 
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Figure 2b. Kaplan-Meier plot of caloric intake using slow nutrient drinking (20 
ml/min) to reach maximum satiety in males and females, p<0.051 (log-rank test). SND 
= slow nutrient drinking. 
Multiple regression analysis showed no influence of age, BMI, or gender on maximum 
tolerated volumes in SND, while RND showed a gender difference but no influence of 
BMI and age. In contrast to this, RWD showed influence of BMI, age and gender over 
maximum tolerated volume.  
Self-assessment of symptoms (maximum score 300) 30 minutes after cessation of 
drinking indicated that SND was associated with significantly higher symptom scores 
than the other drinking tests. Females experienced more symptoms, especially nausea 
and bloating, than did males after each of the three drinking tests. 
 
5.4 Study IV 
A total of 132 patients were enrolled and 128 completed the study. The median age of 
the patients was 38 (range 19-65) years and 65 (49%) were males. H. pylori were 
present at inclusion in 59 (46%) patients. Among H. pylori positive patients 50/59 
(85%) achieved successful eradication.  
MTV determined at baseline was 393 ±202 ml in H. pylori negative group compared to 
381 ±237 ml in H. pylori positive group, the difference in MTV was not significant 
between the groups. On repeat testing following treatment, MTV showed a mean 
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increase of 188 ±102 ml from baseline (<0.001) in H. pylori positive patients and an 
increase of 56 ±77 ml from baseline (p<0.01) in H. pylori negative patients. While a 
decrease of 10 ±34 ml in MTV was noted in patients in which H. pylori eradication was 
unsuccessful.  
A significant inverse relationship was found between baseline MTV and the overall 
symptom score (maximum 56), (r = -0.44) in the whole group. Moreover, MTV at 
baseline showed significant correlations (after Bonferroni correction at p<0.05) with 
4/8 symptoms (epigastric pain: r = 0.45, p<0.00625; epigastric burning: r = 0.43, 
p<0.00625; postprandial fullness: r = 0.56, p<0.00625; and early satiety: r = 0.50, 
p<0.00625; but not with upper abdominal bloating, excessive belching, vomiting, or 
nausea. 
A significant correlation was also observed between the overall change in MTV and 
change in the overall symptom score following treatment for the whole group; (r=-0.61, 
p<0.001, Figure 3). In sub-group analysis, strong relationships were found between the 
change in MTV and the change in the total symptom score among H. pylori positive 
and H. pylori negative patients, (r=-0.60, p<0.001) and (r=-0.52, p<0.001) respectively.  
We found significant correlations (after Bonferroni correction at p<0.05) between the 
change in MTV and changes in individual symptom scores for 4/8 symptoms 
(abdominal pain, abdominal burning, post-prandial fullness and early satiety). 
However, changes in the severity of belching, bloating, nausea and vomiting did not 
show a significant correlation with the change in MTV. On multivariate analysis age 
and weight were found to be independent predictors for MTV but not BMI and H. 
pylori status. 
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Figure 3. Scatter plot of the changes in maximum tolerated volume and symptom 
severity after treatment in patients with functional dyspepsia. Regression line is shown 
for all values (r=-0.61, p<0.001). ○ H. pylori negative patients, ● H. pylori positive 
patients with successful eradication, ■ H .pylori positive patients with unsuccessful 
eradication. 
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6 METHODOLOGICAL CONSIDERATIONS 
 
6.1 Inherent disadvantages of retrospective study design 
Study I was a retrospective analysis of patient and laboratory records. A retrospective 
study uses existing data that have been recorded for purposes other than research. 
Therefore the correlation of EGG and ADM findings with patient’s symptoms 
(potentially useful information) was not possible because of lack of uniform symptom 
recording in the data set.  Moreover there was no control group of healthy individuals 
to compare with and it was not possible to add such a group because of retrospective 
nature of the study design.  
 
6.2  Potential of enhancing alpha error 
During hypothesis testing an alpha error is made when it is concluded that a result is 
positive while actually it is not i.e. a false positive conclusion. In Study I we compared 
22 EGG and 8 ADM variables among various diagnostic groups of motility disorders. 
Such large number of variables could have enhanced the probability of obtaining 
significant differences between the groups (an increase of alpha error). We used logistic 
regression to account for interdependence of variables and to arrive at variables with an 
independent value for predicting diagnoses. A Bonferoni correction could have been 
applied to the correlation matrix but already without such a correction correlations were 
few and of small size.  
 
6.3 Rate of drinking the nutrient liquid 
In study III, MTVs were estimated in healthy volunteers through satiety drinking tests 
on three occasions using different rates of drinking either water or nutrient drink. The 
rate of slow nutrient drinking was 20 ml/min (1 kcal/ml), slightly different from the 
previously published study in which 15 ml/min (1.5 kcal/ml) was used (41). However, 
the caloric value of the nutrient drink in our study (study III) was 20 kcal/min, which is 
close to 22.5 kcal/ml used in the latter study.  
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6.4 Potential effects of lack of blinding and recall bias   
Although not the main aim, study IV also evaluated symptoms among H. pylori 
negative and H. pylori positive patients with FD before and after treatment.  Since the 
treatment was not administered in a blinded and controlled fashion a biased response on 
improvement in symptoms among H. pylori positive patients after treatment can not be 
ruled out. The blinding is particularly important when the response criteria are 
subjective, such as alleviation of pain. In study IV, apparent high rate of symptom 
improvement in patients with FD in which H. pylori was successful eradicated 
compared to patients without H. pylori infection could be due to open label 
administration of anti H. pylori treatment. 
Symptom evaluation was done by using global overall symptom score (GOS) applying 
two days’ symptom recall. It would have been more appropriate if a symptoms diary 
had been kept for a more precise evaluation of symptom improvement and fluctuation. 
Keeping a diary of symptoms can minimize the recall bias very effectively (87).  
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7 DISCUSSION  
This thesis is based on evaluation of certain measurement techniques that may be 
helpful in the management of patients with FD. My thesis clarifies several ambiguities 
regarding clinical usefulness and practicality of these procedures.   
 
7.1 Clinical usefulness of EGG  
Previous studies have demonstrated EGG changes in various motility disorders such as 
diabetic neuropathy, systemic sclerosis, functional dyspepsia, Parkinson's disease, 
intestinal pseudo-obstruction, and after gastric surgery (88-93). Using EGG, the 
relationship between gastric motility and reflux symptoms in patients with non-erosive 
reflux disease (NERD) were analyzed before and after the use of a prokinetic drug (94). 
In that study it was found that gastric dysmotility, assessed by EGG was a significant 
feature in a subset of NERD patients and that dysmotility improved after prokinetic 
treatment. EGG in that study provided a non-invasive technique for evaluating the 
response to treatment objectively along with symptom improvement.  Similarly, in a 
recent paper EGG was used for evaluating patients with diabetic gastroparesis (95).  It 
was observed that patients with a cyclic symptom pattern had more EGG abnormalities 
and more prolonged delays in gastric emptying compared to patients without cyclic 
symptoms. These studies support the application of EGG in the evaluation of patients 
with motility disorders.  
In Study I we found variability in several EGG parameters among patients with various 
motility disorders. However, these parameters could not be linked to a specific disorder 
and thus the discriminatory value of EGG in the diagnosis of various motility disorders 
was questionable. Study I demonstrated some EGG parameters that could discriminate 
slow transit constipation from other motility disorders of the GI tract. Another study 
has reported that healthy normal individuals can also depicting certain abnormalities on 
EGG recording (96). Therefore the careful interpretation of EGG findings is required.  
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7.2 Correlation between EGG and ADM  
A direct comparison of EGG and ADM on a large number of patients with motility 
disorders (Study I) revealed no spatial correlation between the two techniques. This 
indicates that EGG and ADM measure different aspects of gut motor activity. A "one-
to-one" correlation between gastro-duodenal motility parameters and EGG was also not 
found in a recently conducted study (90).   
 
7.3 Efficacy of 14C-UBT 
The high sensitivity and specificity observed for C-UBT (study II) in the diagnosis of 
H. pylori infection is comparable to histology and rapid urease test. Our results are 
corroborated by a study from Japan, which showed a high sensitivity (96.6%) and 
specificity (100%) of C-UBT in the diagnosis of H. pylori infection compared to 
histology, rapid urease test, and PCR (97).  
14
14
A study has suggested using baseline and a 30-minute breath sample after ingesting 75 
mg urea for the diagnosis of H. pylori infection (98). In study II, only one-time test i.e. 
10 minutes after ingestion of a urea capsule was done yielding a high sensitivity and 
specificity. One-time C-UBT test could therefore be more practical and convenient 
for the patients.  
14
There are concerns about the radiation hazards of using radioactive C-isotope of 
carbon in UBT. A recently published study has described that a very minimal emission 
of beta radiation takes place during ingestion of C, which is even less than the daily 
background radiation (99).  
14
14
False positive results of UBT have been reported due to contamination of oral cavity 
and stomach by urease producing non-H. pylori bacteria (100,101). Therefore, in study 
II while validating the C sensitivity and specificity it would have been better if 
thorough mouth cleansing had been done before performing UBT.  
14
Another issue related to the accuracy of UBT for the diagnosis of H. pylori infection is 
the possibility of false negative results of UBT in patients who have been taking proton 
pump inhibitors or H2-antagonists (102). In this era of indiscriminate use of PPIs and 
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their availability over the counter, a random 14C-UBT for the diagnosis of H. pylori 
(without abstinence from PPI) must be interpreted with caution.  
Consensus guidelines have recommended that it is appropriate to eradicate H. pylori if 
found in patients with dyspeptic symptoms as a “test-and-treat” strategy, particularly in 
areas with a high prevalence of gastric carcinoma (103-105). At the primary care level, 
a reliable and portable test is required for the diagnosis of H. pylori infection. Findings 
from Study II and review of the literature suggest that 14C-UBT is efficacious and 
probably one of the best non-invasive tests for the diagnosis of H. pylori infection 
especially for developing countries.  
7.4 Comparison of three satiety drinking tests   
Important observations were made in Study III when healthy volunteers were subjected 
to three different satiety drinking tests. It was found that slow nutrient drinking (SND) 
was associated with more symptom generation than the other two tests. Moreover, it 
was noted that the MTV achieved by study subjects during SND was not influenced by 
age and BMI as compared to rapid nutrient drinking (RND) and rapid water drinking 
(RWD). A previously published study has also demonstrated that caloric nutrient liquid 
used in satiety drinking test is more symptom provoking than water (106). 
In Study III, weak correlations were observed between MTV and BMI in all three 
satiety drinking tests. However, on multiple regression analysis, BMI showed 
significant influence over the MTV values obtained after the RWD test. These 
observations are in agreement with a previous study, which has demonstrated that the 
BMI did not influence MTV beyond its association with age and gender (107). These 
observations indicate that SND is probably a better method of performing satiety 
drinking test because it is less influenced by BMI or age and is associated with more 
symptoms.   
 
7.5 Normal values of satiety drinking tests  
Study III had an added value: normal values of MTV by satiety drinking tests using 
slow (20 ml/min) and rapid (100 ml/min) nutrient drinking and water drinking at 100 
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ml/min for this region were obtained. The study also demonstrated that MTV 
determined by rapid water drinking was comparable to published values from the 
Western world (29, 41, and 69,108).  
7.6 MTV as a surrogate marker for symptom severity in 
dyspepsia 
A significant correlation between MTV and dyspepsia symptom scores was observed in 
Study IV in patients with FD. Additionally, some individual dyspepsia symptom scores 
also correlated well with MTV. These observations suggest that MTV estimated by 
SND satiety drinking test can be used as a surrogate marker for symptom evaluation in 
patients with FD. To our best knowledge, no other study has described MTV as a 
surrogate marker for the severity of dyspepsia symptoms.  
7.7 Relationship between age and MTV 
A weak but inverse correlation was observed between age and MTV in healthy 
volunteers as well as in patients with FD in study III and IV respectively. This inverse 
relationship between age and MTV is quite in contrast to Western data that has 
indicated an increase in MTV with the increase in age (107). The nature of this inverse 
relationship is unclear and no other study has demonstrated such effect of age on MTV 
using satiety drinking tests. Interestingly, a recently published study has shown that 
symptoms of pain and nausea are inversely correlated with age following a 
standardized nutrient challenge (109).  
The satiety drinking test was first applied more than a decade ago in an attempt to have 
a simple non-invasive test for the assessment of gastric accommodation. A significant 
correlation has been observed between gastric accommodation measured by barostat 
and total calories consumed during a nutrient drink test administered at 15 ml/min (41, 
69). However, in another study using nutrient drink at 100 ml/min, no such relationship 
was noted between caloric consumption during drinking test and gastric 
accommodation estimated by barostat (29). Others have found no relationship between 
gastric accommodation assessed by SPECT and a satiety drinking test (110). Only a 
modest relationship was found between gastric emptying and satiety drinking test 
(111). Moreover, there is evidence that certain psychosocial factors might influence the 
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outcome of satiety drinking tests (112). Therefore, it remains questionable what the 
satiety drinking test actually measures. In view of this ambiguity, the terms "slow 
nutrient tolerance test" and "nutrient challenge test" have been suggested to replace 
“satiety drinking test”. The nutrient challenge test assesses global stomach sensation 
rather than just being the descriptor of single motor phenomena (113). 
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8 CONCLUSIONS 
This thesis concluded that 
EGG is a technique for evaluation of gastric motility whose discriminatory power to 
diagnose a motility disorder is very limited. The results of study I and review of the 
literature did not support any practical clinical utility of this technique in patients with 
gastrointestinal motility disorders. Therefore EGG will most likely remain a research 
tool only, in years to come.  
14C-UBT is a reliable, highly sensitive, specific and economical test for the diagnosis of 
H. pylori infection. The amount of radiation exposure is negligible. Studies are required 
to determine its sensitivity in patients who are currently taking PPI or other acid 
lowering agents.  
Satiety drinking test is a simple and inexpensive technique for evaluation of patients 
with FD.  Use of a slower rate for nutrient drinking is better and yields a more 
meaningful measurement of MTV compared to nutrient drinking at a rapid rate or water 
drinking.  
Changes in satiety drinking test volumes correlated well with changes in symptom 
severity in patients with FD. Therefore satiety drinking test might be useful as an 
adjunct to symptom score for objective assessment of clinical outcome in patients with 
FD. 
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9  FUTURE PERSPECTIVES  
The electrogastrography technique is still evolving. Recent studies have focused on 
understanding the gastric slow wave changes demonstrated by EGG in response to 
proximal gut surgery, and the evaluation of certain novel pharmacotheraputic agents 
(93,114). A new device has recently been introduced (which is applied through 
laparoscope) for investigating the effect of gastric surgical procedure on gastric slow 
wave activities (115). However the clinical usefulness of EGG remains unproven.  
Breath tests using the radioactive carbon isotope 14C were developed 3-4 decades ago 
for measuring exocrine pancreatic function, intestinal absorption, and liver function. 
With increasing awareness of radiation hazards 14C has been replaced by a stable, non-
radiating carbon isotope, 13C in these breath test. For studies in children and pregnant 
women, and for repeated studies in adults, the use of stable isotopically labeled 
substrates is preferable and safe. High resolution mass spectrometry is the gold 
standard for measuring the slight mass difference of one neutron between 13C-labelled 
carbon dioxide and the naturally most common carbon dioxide with 12C. The 
development of non-dispersive isotope selective infrared spectrometers (NDIRS) 
opened up a lower-priced analytical alternative with adequate precision (116,117). 
Operation and handling of NDIRS is easy, even for non-experienced users. At the push 
of a button, breath samples can be analyzed within about 60 seconds. This enables not 
only the performance, but now also the analysis of 13C-breath tests in primary care 
settings. Measurement of gastric emptying, orocecal transit time and carbohydrate 
assimilation are some potential areas of further application of 13C breath test by using 
NDIRS.  
Satiety drinking tests have the potential for clinical usefulness in routine practice 
especially for interventional trials as an adjunct to other evaluation techniques and 
symptom severity scores. In a recent study the role of endocannabinoid system in the 
regulation of motility and sensitivity of stomach was evaluated using nutrient liquid 
challenge test (118). In another study, water load test was used to evaluate symptoms in 
response to gastric distension before and after PPI therapy (119). These studies reflect 
the clinical application of a simple measurement technique, which is inexpensive and 
helpful in the evaluation of patients with FD and other functional proximal gut 
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disorders. However, there is a need to standardize the technique for uniform application 
in terms of the choice of the drink and rate of ingestion. 
SmartPill™, is a wireless capsule that continuously measures the temperature, pH and 
pressure in the GI tract. This capsule may be a useful technique in the future for 
determination of transit times in different parts of the GI tract without radiation and 
much invasiveness (120). Likewise, MRI (non-invasive and free from radiation hazard) 
is a promising technique for the assessment of gastric emptying and antral wall motion 
(51). 
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